Meta Health Limited (SGX:5DX) said it has used SG$882,000 of the SG$1.4 million raised from its renounceable non-underwritten rights issue, mainly for debt repayment and working capital, according to a Friday filing on the Singapore Exchange.
The healthcare technology firm allocated SG$790,000 for loan repayments, using SG$252,000 so far, including full repayment of a SG$150,000 loan from MWA Capital due March 2025.
Another SG$640,000 was set aside for corporate and working capital needs, of which SG$630,000 has been spent on employee expenses, legal fees, rental, and corporate costs.